Maryland State Retirement & Pension System’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284K Sell
33,912
-690
-2% -$6.29K ﹤0.01% 1243
2026
Q1
$312K Sell
34,602
-276
-0.8% -$4.36K 0.01% 1087
2025
Q4
$636K Buy
34,878
+572
+2% +$9.64K 0.01% 692
2025
Q3
$503K Sell
34,306
-35,854
-51% -$615K 0.01% 809
2025
Q2
$1.28M Buy
70,160
+1,143
+2% +$23.3K 0.03% 458
2025
Q1
$1.37M Sell
69,017
-10,590
-13% -$183K 0.03% 412
2024
Q4
$1.37M Buy
79,607
+897
+1% +$16.9K 0.03% 477
2024
Q3
$1.57M Buy
+78,710
New +$1.22M 0.03% 432

Other funds holding ADMA

Maryland State Retirement & Pension System's ADMA Position: Q2 2026 in Review

Maryland State Retirement & Pension System reduced its ADMA Biologics (ADMA) stake by 2% in Q2 2026, selling an estimated $6.29K and leaving 33,912 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Maryland State Retirement & Pension System first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.57M in Q3 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Maryland State Retirement & Pension System held 33,912 shares of ADMA Biologics worth $284K as of Q2 2026.
  • Maryland State Retirement & Pension System sold 690 ADMA Biologics shares in Q2 2026, an estimated $6.29K.
  • ADMA Biologics made up ﹤0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #1243 holding.
  • Maryland State Retirement & Pension System first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Maryland State Retirement & Pension System's ADMA Biologics position peaked at $1.57M in Q3 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.